Summary of opinion: Praluent,alirocumab, 12/10/2023, Positive
Submitted by Anonymous (not verified) on 13 October 2023 - 12:37
Summary of opinion: Praluent,alirocumab, 12/10/2023, Positive
Summary of opinion: Praluent,alirocumab, 12/10/2023, Positive
Summary of opinion: Rezzayo,rezafungin, 12/10/2023, Positive
Summary of opinion: Elrexfio,elranatamab, 12/10/2023, Positive
Summary of opinion: Loargys,Pegzilarginase, 12/10/2023, Positive
Summary of opinion: Veyvondi,vonicog alfa, 12/10/2023, Positive
Buying medicines online
Summary of opinion: Agamree,Vamorolone, 12/10/2023, Positive
New treatment option for heavily pre-treated multiple myeloma patients
Summary of opinion: Vueway,Gadopiclenol, 12/10/2023, Positive
Summary of opinion: Albrioza,sodium phenylbutyrate,Ursodoxicoltaurine, 12/10/2023, Negative